Company Sevion Therapeutics Inc OTC Bulletin Board
Equities
US81834Q1040
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Sumit Aggarwal
CEO | Chief Executive Officer | - | 01/21/01 |
Daniel Geffken
DFI | Director of Finance/CFO | 67 | 01/20/01 |
Ali Hariri
CTO | Chief Tech/Sci/R&D Officer | - | 08/21/08 |
Barbara Ryan
IRC | Investor Relations Contact | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Steven Rubin
BRD | Director/Board Member | 63 | 01/14/01 |
Alan Walts
BRD | Director/Board Member | 64 | 01/21/01 |
Sumit Aggarwal
CEO | Chief Executive Officer | - | 01/21/01 |
Lindsay Androski
BRD | Director/Board Member | - | 05/22/05 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 3,143,390 | 3,006,085 ( 95.63 %) | 0 | 95.63 % |
Company contact information
Sector
Sales per region
1st Jan change | Capi. | |
---|---|---|
+3.99% | 11TCr | |
+11.45% | 11TCr | |
-12.69% | 2.23TCr | |
-3.70% | 2.19TCr | |
-6.03% | 1.86TCr | |
-35.21% | 1.81TCr | |
-10.26% | 1.7TCr | |
+2.96% | 1.37TCr | |
+36.80% | 1.24TCr |
- Stock Market
- Equities
- ELOX Stock
- Stock
- Company Sevion Therapeutics Inc